Israel Biotech Fund

Israel Biotech Fund is a venture capital firm investing exclusively in Israeli and Israeli-related biotechnology and pharmaceutical companies developing drugs.

Venture Capital Active Rehovot, Israel Est. 2014
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
4
in our dataset
Rounds participated
4
Rounds led
1
Rounds' value
$33.0M
total disclosed, rounds participated
Stages
Pre-Seed, A Round, Seed

About

Israel Biotech Fund (IBF) is a venture capital firm based in Rehovot, Israel, that seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israeli-based biotech companies. The fund invests exclusively in biotech companies developing drugs at or near clinical stages. IBF provides its portfolio companies with hands-on guidance and resources for long-term sustainable growth, leveraging a team of nearly 30 Venture Advisors who are industry leaders and professionals. This approach aims to enhance company value and investor capital appreciation, while strengthening Israel's biotech industry.

Portfolio · 4

Peles Therapeutics
Monoclonal Antibody Treatment for Peripheral Artery Disease
Led ★ 1 round Latest: 2021-07
Tamarix Pharma
Therapies for Apoptosis-driven Diseases
1 round Latest: 2021-01
TPCera
Immunomodulatory Treatment for Autoimmune Diseases
1 round $3.0M committed Latest: 2018-07
Pharma Two B
Innovative Combinations of Previously Approved Drugs
1 round $30.0M committed Latest: 2017-02

Investment activity

4 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences18

Funds · 2

  • 2 — $100M Apr 2021
  • 1 — $66M Oct 2016

Q&A

What is Israel Biotech Fund's primary investment focus?
Israel Biotech Fund invests exclusively in Israeli and Israeli-related biotech companies across all development stages.
When was Israel Biotech Fund founded?
Israel Biotech Fund started its activity in late 2015.
What is the most recent fund raised by Israel Biotech Fund?
Israel Biotech Fund closed its second fund, Fund 2, in April 2021, raising $100M.
Can you name some of Israel Biotech Fund's notable exits?
Israel Biotech Fund has seen exits including BioSight, which was acquired by Ayala Pharmaceuticals in October 2023, and Vidac Pharma, which went public in March 2023.
Which investment stages does Israel Biotech Fund typically target?
Israel Biotech Fund invests across Pre-Seed, Seed, and A Round stages.
Who are some of the founding partners of Israel Biotech Fund?
The founding partners of Israel Biotech Fund include Yuval Cabilly, Ido Zairi, and David Sidransky.
What is Israel Biotech Fund's approach to supporting its portfolio companies?
Israel Biotech Fund provides its portfolio companies with hands-on guidance and necessary resources for long-term sustainable growth.
What is the sector concentration of Israel Biotech Fund's portfolio?
Israel Biotech Fund's portfolio is entirely concentrated in the Health Tech & Life Sciences sector, with 18 portfolio companies in this area.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteibf.fund
LinkedInlinkedin.com/company/10267153

Identifiers & details

Founded2014

Radar intelligence

Web history (Wayback)

Domainibf.fund

Certificate / subdomain footprint

Subdomains2